EA
AGN

Euclid Advisors’s Allergan Inc AGN Stock Holding History

Euclid Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-154,930
Closed -$27.6M – 561
2014
Q3 		$27.6M Buy
154,930
+9,190
+6% +$1.53M 0.2% 113
2014
Q2 		$24.7M Sell
145,740
-23,594
-14% -$3.67M 0.17% 137
2014
Q1 		$21M Buy
169,334
+47,260
+39% +$5.75M 0.16% 134
2013
Q4 		$13.6M Sell
122,074
-6,470
-5% -$618K 0.11% 184
2013
Q3 		$11.6M Buy
128,544
+26,809
+26% +$2.41M 0.12% 184
2013
Q2 		$8.57M Buy
+101,735
New +$10.6M 0.11% 219

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Euclid Advisors's AGN Position: Q4 2014 in Review

Euclid Advisors sold out of Allergan Inc (AGN) in Q4 2014, closing a stake of 154,930 shares — an estimated $27.6M sold.

Euclid Advisors first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $27.6M in Q3 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Euclid Advisors reported no remaining Allergan Inc position as of Q4 2014 after selling out during the quarter.
  • Euclid Advisors sold 154,930 Allergan Inc shares in Q4 2014, an estimated $27.6M.
  • Euclid Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Euclid Advisors's Allergan Inc position peaked at $27.6M in Q3 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Euclid Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.